Skip to content
Search AI Powered

Latest Stories

Over two-thirds of BAME pharmacy workforce yet to be risk-assessed for susceptibility to Covid-19

More than two-thirds of black, Asian and minority ethnic (BAME) pharmacy workforce across primary and secondary care have yet to be risk-assessed for Covid-19, a new survey has revealed.

This comes nearly two months after NHS England sent a letter to community pharmacies on April 29, which advised employers to risk-asses staff at potentially greater risk.


Recommendations from a Public Health England report on the impact of Covid-19 on BAME groups have reinforced the importance of risk assessment, while Pharmacists' Defence Association has launched a toolkit to help mitigate virus risks in pharmacies.

The latest survey from the Royal Pharmaceutical Society (RPS) and the UK Black Pharmacists Association (UKBPA) reveals that 78 per cent of black pharmacists and pre-regs believe they were at risk of COVID-19 and changes to their working practices are required.

Both RPS and UKBPA have already called for individual risk assessments to be mandatory for BAME staff and intend to re-survey pharmacists and pre-regs in a month’s time to check if there has been any improvement.

The RPS and UKBPA have also written to ministers in England, Wales and Scotland, calling for support for BAME pharmacists and team members.

“It’s shocking that pharmacists across primary and secondary care, especially colleagues from BAME backgrounds, are telling us they have still not been risk assessed, RPS President Sandra Gidley said, adding: “Employers must take urgent action to address this and ensure pharmacists and their team can continue looking after patients safely.

The RPS has developed a position statement in consultation with the UKBPA and The Association of Pharmacy Technicians UK (APTUK) to support pharmacy teams on the frontline. It urges employers to undertake appropriate risk assessments for all pharmacy staff and implement mitigating actions to reduce risk to pharmacy staff from all vulnerable groups.

UKBPA President Elsy Gomez Campos said: “It is concerning to hear that pharmacy colleagues are still waiting for a Covid-19 risk assessment. Pharmacy staff need to feel safe if they are going to do their job without fear or anxiety. We now know that Covid-19 has negatively affected the BAME population the most, including health and care staff.

APTUK President Liz Fidler said the association was committed to working with others across the profession so that members, pharmacy technicians and support staff from BAME backgrounds receive appropriate risk assessments.

The survey received 380 responses between June 12 and June 22, of which 236 respondents were from a BAME background.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less